EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cord Blood-Derived Versus Homologous Donor Platelet-Rich Plasma (PRP) in Early Knee Osteoarthritis: A Single-Center, Randomized, Double-Blind Pilot Clinical Trial

Salvatore Alessio Angileri iD, Enrica Cristini, Simone Mazzola, Giovanni Maria Rodà, Chloe Yeabin Jung iD, Salvatore Valentino, Stefania Villa iD, Tiziana Montemurro, Larysa Mykhailova iD, Letizia Di Meglio, Simone Raoul Mortellaro, Vittoria Chiarpenello und 5 weitere

Bioengineering · 14.07.2026 · 13 (7) · 806

DOI: 10.3390/bioengineering13070806 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioengineering, online erschienen am 14.07.2026. Verfasst von Salvatore Alessio Angileri und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostic and Interventional Radiology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Via Francesco Sforza 28, 20122 Mila…. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Ministry of Health—Current research IRCCS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Intra-articular platelet-rich plasma (PRP) injections represent a promising biological treatment for early-stage knee osteoarthritis (KOA). As cord blood-derived PRP (CB-PRP) contains higher levels of bioactive mediators, this prospective study aimed to compare the efficacy and safety of CB-PRP versus homologous donor PRP (HD-PRP) in patients with early KOA and to evaluate whether CB-PRP results in greater clinical improvement. Fifty-one patients aged 46–70 years with Kellgren–Lawrence grade 1–2 were randomized to receive either CB-PRP or HD-PRP. Each underwent three intra-articular injections at four-week intervals. Outcomes included pain-related overall health perception assessed by the EuroQol Visual Analogue Scale (EQ-VAS), function measured with the Knee Injury and Osteoarthritis Outcome Score (KOOS), and quadriceps muscle strength evaluated by dynamometry. Assessments were performed at baseline and at 1, 2, 3, 6, and 12 months. Both groups showed improvements in pain and function over 12 months, with no statistically significant between-group differences (p = 0.46). EQ-VAS increased from 59 ± 19 to 83 ± 9 in the CB-PRP group and from 59 ± 18 to 77 ± 18 in the HD-PRP group. KOOS improved from 50 ± 25 to 68 ± 23 and from 38 ± 28 to 59 ± 24, respectively. Quadriceps strength showed no intergroup differences. Adverse events were mild and self-limiting. Both treatments demonstrated comparable clinical benefits and favorable safety profiles.

Schlagwörter

Stichwörter der Autor:innen

cartilage regenerationintra-articular injectionknee osteoarthritisplatelet-rich plasmaregenerative medicineumbilical cord blood

Autor:innen und Institutionen

  • Department of Diagnostic and Interventional Radiology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Via Francesco Sforza 28, 20122 Milan, Italy.
  • Division of Orthopedic Surgery and Traumatology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Via Francesco Sforza 35, 20122 Milan, Italy.
  • Postgraduate School of Diagnostic and Interventional Radiology, Università degli Studi di Milano, Via Festa del Perdono 7, 20122 Milan, Italy.
  • Department of Transfusion Medicine and Hematology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Via Francesco Sforza 28, 20122 Milan, Italy.
  • Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Via Pace 9, 20122 Milan, Italy.
  • Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Via Festa del Perdono 7, 20122 Milan, Italy.

ORCID-Profile: Salvatore Alessio Angileri, Chloe Yeabin Jung, Stefania Villa, Larysa Mykhailova, Luigi Piero Solimeno

Förderung

  • Italian Ministry of Health—Current research IRCCS

Zitieren

APA

Angileri, S. A., Cristini, E., Mazzola, S., Rodà, G. M., Jung, C. Y., Valentino, S., Villa, S., Montemurro, T., Mykhailova, L., Di Meglio, L., Mortellaro, S. R., Chiarpenello, V., Lanza, C., Gualtierotti, R., Prati, D., Carrafiello, G., & Solimeno, L. P. (2026). Cord Blood-Derived Versus Homologous Donor Platelet-Rich Plasma (PRP) in Early Knee Osteoarthritis: A Single-Center, Randomized, Double-Blind Pilot Clinical Trial. Bioengineering, 13(7), 806. https://doi.org/10.3390/bioengineering13070806

Vancouver

Angileri SA, Cristini E, Mazzola S, Rodà GM, Jung CY, Valentino S, et al. Cord Blood-Derived Versus Homologous Donor Platelet-Rich Plasma (PRP) in Early Knee Osteoarthritis: A Single-Center, Randomized, Double-Blind Pilot Clinical Trial. Bioengineering. 2026;13(7):806. doi:10.3390/bioengineering13070806

BibTeX
@article{Angileri2026,
  author = {Angileri, Salvatore Alessio and Cristini, Enrica and Mazzola, Simone and Rodà, Giovanni Maria and Jung, Chloe Yeabin and Valentino, Salvatore and Villa, Stefania and Montemurro, Tiziana and Mykhailova, Larysa and Di Meglio, Letizia and Mortellaro, Simone Raoul and Chiarpenello, Vittoria and Lanza, Carolina and Gualtierotti, Roberta and Prati, Daniele and Carrafiello, Gianpaolo and Solimeno, Luigi Piero},
  title = {Cord Blood-Derived Versus Homologous Donor Platelet-Rich Plasma (PRP) in Early Knee Osteoarthritis: A Single-Center, Randomized, Double-Blind Pilot Clinical Trial},
  journal = {Bioengineering},
  year = {2026},
  volume = {13},
  number = {7},
  pages = {806},
  doi = {10.3390/bioengineering13070806}
}
Kostenlos starten →